NEUROTHERAPEUTICS LTD
Executive Summary
Neurotherapeutics Ltd is a technology-driven medical equipment manufacturer strategically positioned within the electrotherapeutic device niche. Its strong academic and management leadership, supported by recent capital injections, provides a solid foundation to advance product development and commercialization. However, the company must carefully manage its cash burn, navigate regulatory hurdles, and build operational capacity to capitalize on growth opportunities and mitigate competitive and market risks.
View Full Analysis Report →- Legal registered address
- The Ingenuity Centre University Of Nottingham Innovation Park Triumph Road Nottingham England NG7 2TU Copied!
Latest financial results as of 30 July 2025- Cash in bank
- £2.00m
- Current assets
- £2.24m
- Fixed assets
- £61.47k
- Current creditors
- £104.26k
- Shareholders funds
- £4.69m
View full financial accounts- Cash in bank
- £2.00m
- Current assets
- £2.24m
- Fixed assets
- £61.47k
- Current creditors
- £104.26k
- Shareholders funds
- £4.69m
- Company number
- 13198315 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 10 February 2025
Next statement due by 24 February 2026
Nature of business (SIC)
26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
Previous company names
| Name | Date previous name changed |
|---|---|
| NEUROTHERAPEUTICS SOLUTIONS LIMITED | 7 October 2021 |
Latest company documents
| Date | Description |
|---|---|
| 23/07/2523 July 2025 New | Total exemption full accounts made up to 2024-12-31 |
| 22/05/2522 May 2025 | Statement of capital following an allotment of shares on 2025-05-16 |
| 18/02/2518 February 2025 | Confirmation statement made on 2025-02-10 with updates |
| 31/12/2431 December 2024 | Annual accounts for year ending 31 Dec 2024 |
| 07/11/247 November 2024 | Statement of capital following an allotment of shares on 2024-10-09 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company